| Name | 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiine 10,10-dioxide |
|---|---|
| Synonyms |
Phenoxathiin,3-fluoro-7-(2,2,2-trifluoroethoxy)-,10,10-dioxide
CX157 CX-157 |
| Description | CX-157 is a reversible inhibitor of monoamine oxidase-A (MAO-A) with an EC50 of 19.3 ng/mL. |
|---|---|
| Related Catalog | |
| Target |
EC50: 19.3 ng/mL (MAO-A)[1] |
| In Vivo | CX-157 is a reversible inhibitor of monoamine oxidase-A (MAO-A) with an EC50 of 19.3 ng/mL. CX-157 is an investigational compound currently in development for the treatment of major depressive disorder (MDD). Mechanistic studies in animals have shown that CX-157 acts to inhibit MAO-A activity in a reversible and competitive manner, elevating brain levels of monoamine neurotransmitters[1]. |
| References |
| Molecular Formula | C14H8F4O4S |
|---|---|
| Molecular Weight | 348.27000 |
| Exact Mass | 348.00800 |
| PSA | 60.98000 |
| LogP | 4.78610 |
| Storage condition | 2-8℃ |